Category: Prescription Drugs
Docetaxel-carboplatin-trastuzumab, also known as TCH, is a regimen that may be used for the treatment of breast cancer. It contains the anticancer agents docetaxel (Taxotere®), carboplatin, and trastuzumab (Herceptin®).
Side effects as an overall problem
Currently taking Docetaxel-carboplatin-trastuzumab (TCH)
|This item is relevant to you: 6 months - 1 year||1||
What people switch to and from
Patients stopped taking Docetaxel-carboplatin-trastuzumab (TCH) and switched to:
|This item is relevant to you: Cetuximab (Erbitux)||1||